Improving Health Behavior and Outcomes After Angioplasty
1 other identifier
interventional
660
1 country
1
Brief Summary
The objective of this randomized trials is to evaluate, among coronary artery disease patients who have just had either angioplasty or stents, whether a novel intervention based on feedback of individualized risk profiles framed as the opportunity to reduce one's biological age is more effective after two years in reducing mortality and major cardiovascular morbidity (specifically, myocardial infarction, stroke, class II-IV angina, and severe ischemia) than the standard risk reduction approach, which is framed as one's opportunity to reduce future risk. The novel strategy is based on the theory of net-present value and is tested in coronary artery disease patients who have a high risk of adverse outcomes by two years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 1999
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 29, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2004
CompletedFirst Submitted
Initial submission to the registry
November 3, 2005
CompletedFirst Posted
Study publicly available on registry
November 4, 2005
CompletedOctober 29, 2018
October 1, 2018
5 years
November 3, 2005
October 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Mortality
Myocardial Infarction
Angina
Severe ischemia on non-invasive testing
Stroke
Secondary Outcomes (3)
a. To determine whether patients who receive the net-present value intervention have more improvements in their risk factor profile than those in the control group at two years.
b. To determine whether the net-present value intervention will enable patients to sustain behavioral change over the long-term.
c. To determine whether the net-present value intervention will improve overall functional status and prevent further disability.
Study Arms (2)
1
NO INTERVENTIONThis is the control group, which will be monitor. No intervention will be delivered to this group.
2
EXPERIMENTALThis group received the experimental intervention. This is an intervention based on feedback of individualized risk profiles framed as the opportunity to reduce one's biologic age. Net-present value of individual health behaviors in years.
Interventions
Eligibility Criteria
You may qualify if:
- All patients undergoing coronary artery catheterization who are found to have at least single vessel stenosis and who have had revascularization with angioplasty or coronary artery stenting will be eligible for enrollment. Patients must be able to provide informed consent within the one week after the procedures.
You may not qualify if:
- Patients must be verbally fluent in English. To ascertain this, we ask the patient to rate their fluency on a scale of 1-10 (with 10 as best), and if the score is 7 or more, they are approached for consent. The patient must be able to provide their own consent without translation.
- Enrollment in other trials designed to modify post-procedure behaviors.
- Patients who refuse to participate will be excluded.
- If at any time prior to enrollment in the study, the patient's cardiologist determines that the patient should not participate in this study, the patient will not be enrolled in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York Presbyterian College-Weill Medical Center
New York, New York, 10021, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Mary E Charlson, MD
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- The William T. Foley Distinguished Professor in Medicine
Study Record Dates
First Submitted
November 3, 2005
First Posted
November 4, 2005
Study Start
April 1, 1999
Primary Completion
March 29, 2004
Study Completion
March 29, 2004
Last Updated
October 29, 2018
Record last verified: 2018-10